Biocon And Mylan Get CRL From FDA For Lantus Rival

 
• By Penelope MacRae
  
FDA
The FDA has issued a CRL on Biocon's insulin glargine • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products